HomeCompareCMPI vs MCD

CMPI vs MCD: Dividend Comparison 2026

CMPI yields 19.05% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $9.7K in total portfolio value· pulled ahead in Year 10
10 years
CMPI
CMPI
● Live price
19.05%
Share price
$10.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$68.9K
Annual income
$6,079.53
Full CMPI calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — CMPI vs MCD

📍 MCD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMPIMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMPI + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMPI pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMPI
Annual income on $10K today (after 15% tax)
$1,619.05/yr
After 10yr DRIP, annual income (after tax)
$5,167.60/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $17,125.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMPI + MCD for your $10,000?

CMPI: 50%MCD: 50%
100% MCD50/50100% CMPI
Portfolio after 10yr
$73.7K
Annual income
$16,153.62/yr
Blended yield
21.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

CMPI
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMPI buys
0
MCD buys
0
No recent congressional trades found for CMPI or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMPIMCD
Forward yield19.05%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$68.9K$78.5K
Annual income after 10y$6,079.53$26,227.70
Total dividends collected$38.2K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: CMPI vs MCD ($10,000, DRIP)

YearCMPI PortfolioCMPI Income/yrMCD PortfolioMCD Income/yrGap
1$12,605$1,904.76$10,815$334.85+$1.8KCMPI
2$15,731$2,243.84$11,826$491.71+$3.9KCMPI
3$19,449$2,617.14$13,123$730.06+$6.3KCMPI
4$23,835$3,024.07$14,853$1,100.07+$9.0KCMPI
5$28,967$3,463.51$17,257$1,690.61+$11.7KCMPI
6$34,928$3,933.88$20,752$2,667.01+$14.2KCMPI
7$41,806$4,433.18$26,103$4,354.83+$15.7KCMPI
8$49,692$4,959.03$34,794$7,437.78+$14.9KCMPI
9$58,679$5,508.79$49,926$13,461.60+$8.8KCMPI
10← crossover$68,866$6,079.53$78,550$26,227.70$9.7KMCD

CMPI vs MCD: Complete Analysis 2026

CMPIStock

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.

Full CMPI Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this CMPI vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMPI vs SCHDCMPI vs JEPICMPI vs OCMPI vs KOCMPI vs MAINCMPI vs YUMCMPI vs QSRCMPI vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.